首页|清瘟护肺颗粒免疫调节潜在药效物质及作用机制研究

清瘟护肺颗粒免疫调节潜在药效物质及作用机制研究

扫码查看
目的 基于网络药理学、分子对接技术与体内外实验研究清瘟护肺颗粒(QWHF)免疫调节潜在药效成分和作用机制.方法 通过BATMAN-TCM数据库进行成分-靶点预测,GeneCards数据库查询免疫调节相关靶点,构建交集靶点的相互作用网络图,并筛选出核心靶点,使用DVIAD数据库进行GO和KEGG富集分析.细胞实验选用RAW264.7巨噬细胞系,采用CCK-8法检测QWHF对细胞活力的影响,Griess法测定NO释放量,ELISA法测定TNF-α、IL-1 β和IL-6释放量;体内实验采用腹腔注射环磷酰胺80 mg/kg建立小鼠免疫低下模型,设置空白对照组、模型组、QWHF低、高(4.3、8.6 g/kg)剂量组,连续灌胃14 d后检测各组小鼠脾脏和胸腺指数、血常规、血清及组织的免疫因子水平.结果 获得QWHF免疫调节潜在靶点460个,核心靶点43个,潜在药效成分65个.分子对接结果表明,异甘草素、白术内酯Ⅲ、甘草素等成分与AKT1、TNF、IL-6等受体均有较好的结合能力.结果 表明,400~1 000 μg/mL QWHF能显著提高RAW264.7细胞NO分泌量,并不同程度刺激细胞上清液中TNF-α、IL-1 β和IL-6的释放;QWHF低、高剂量组均可显著升高免疫低下小鼠的脾脏指数和白细胞、中性粒细胞与淋巴细胞含量,并使血清、脾脏和胸腺TNF-α、IL-1 β水平和血清IgG、IgM及脾脏SOD水平显著提高.结论 本研究初步揭示了 QWHF免疫调节的药效物质基础及作用机制,为其临床研究和进一步开发提供了参考.
Study on Potential Pharmacological Substances and Mechanisms of Qingwen Hufei Granules in Immune Regulation
Objective To explore the potential pharmacological substances and mechanisms of Qingwen Hufei Granules(QWHF)in immune regulation applying network pharmacology and molecular docking technology combined with in vitro and in vivo experiments.Methods Component-target prediction was performed using the BATMAN-TCM database,and targets related immune regulatory were queried through the GeneCards database.The interaction network diagram of intersecting targets was constructed,and core targets were screened.GO and KEGG enrichment analysis were performed using the DVIAD database.The effect of BWJD on RAW264.7 macrophage cell viability was detected using CCK-8 method.Moreover,the release of NO,TNF-α,IL-1β and IL-6 were measured using Griess and ELISA method respectively.The immunosuppressed mouse model was established by cyclophosphamide of intraperitoneal injection at a dose of 80 mg/kg in vivo experiments.Blank control group,model group,QWHF low and high(4.3,8.6 g/kg)dose groups were set up.After intragastric administration for 14 d,the hemogram,spleen and thymus index,immune factor levels in serum and tissue of each group were measured.Results Total of 460 potential targets were identified for the immune regulation in QWHF,and 43 core targets were screened,and 65 potential pharmacological components were identified.The molecular docking results showed that isoliquiritigenin,atractylenolide Ⅲ and liquiritigenin all had good binding ability with receptors such as AKT1,TNF and IL-6.The results indicate that the range of 400 and 1 000 μg/mL QWHF could significantly increase NO secretion,and stimulate release of the inflammatory factor TNF-α,IL-1β and IL-6 in varying degrees.Both low and high dose of QWHF groups could significantly increased the spleen index,the content of white blood cells,neutrophils,and lymphocytes in immunocompromised mice,meanwhile TNF-α and IL-1 β in serum,spleen and thymic,as well as IgG,IgM in serum and SOD secretion in thymic also increased significantly.Conclusion The study preliminarily revealed the material basis and mechanism of immune regulatory efficacy of QWHF,which provide a reference for its clinical research and further development.

Qingwen Hufei Granulesnetwork pharmacologymolecular dockingimmune regulationpharmacological substances

张笑颜、张红、龙凯花、刘满军、靳景瑞、孙婷婷、支文冰、李晔、张德柱、马艳、刘洋

展开 >

陕西省中医药研究院/陕西省中医医院,陕西 西安 710003

中国医科大学,辽宁沈阳 110001

陕西盘龙药业集团股份有限公司,陕西西安 710000

中国中医科学院中医临床基础医学研究所,北京 100700

展开 >

清瘟护肺颗粒 网络药理学 分子对接 免疫调节 药效物质

2024

现代中药研究与实践
安徽中医药高等专科学校,

现代中药研究与实践

CSTPCD
影响因子:0.409
ISSN:1673-6427
年,卷(期):2024.38(5)